Appeals court limits access to abortion drug by telemedicine

A federal appeals court has curtailed access to an abortion-inducing drug by telemedicine appointment and mail, putting on hold a Biden-era policy that had allowed mifepristone to be prescribed online and delivered by post.

More from The Washington Times stories: News

California Gov. Newsom calls WHCD shooting 'evil,' blames Trump for political climate

The Washington Times stories: News·1

Officials recommend that commuters using NJ Transit work from home during World Cup

The Washington Times stories: News·1

Taiwan's president lands in Eswatini in a trip delayed by lack of overflight clearance

The Washington Times stories: News·1

Nebraska becomes first state to impose Medicaid work requirements before OBBB deadline

The Washington Times stories: News·1

Germany focuses on shared interests after U.S. announces troop drawdown

The Washington Times stories: News·2

Drone kills two in Kherson minibus strike, as Russia claims front-line progress

The Washington Times stories: News·4